Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2020-06-01
DOI
10.1080/17425255.2020.1764939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia
- (2019) Antonio C. Arrieta et al. PLoS One
- Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
- (2019) Andreas H Groll et al. CLINICAL INFECTIOUS DISEASES
- Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
- (2019) Jill Adler-Moore et al. CLINICAL INFECTIOUS DISEASES
- Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis
- (2019) Hui-Chen Su et al. Infection and Drug Resistance
- Treatment by posaconazole tablets did not reduced variability of posaconazole trough concentrations compared to posaconazole suspension
- (2019) Elodie Gautier-Veyret et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal drugs: What brings the future?
- (2019) Ruth Van Daele et al. MEDICAL MYCOLOGY
- Low central nervous system posaconazole concentrations during cerebral phaeohyphomycosis
- (2019) François Barde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism
- (2019) Minh-Vu H Nguyen et al. CLINICAL INFECTIOUS DISEASES
- Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level
- (2019) Jihyu Oh et al. MYCOSES
- Implications for IV posaconazole dosing in the era of obesity
- (2019) Roeland E Wasmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections
- (2019) Alexander F. A. D. Schauwvlieghe et al. MYCOSES
- Primary fungal prophylaxis in hematological malignancy: A network meta-analysis of randomized controlled trials
- (2018) Cho-Hao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with hematological malignancies
- (2018) Pier Giorgio Cojutti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison
- (2018) Mar Tormo et al. MYCOSES
- Posaconazole–digoxin drug–drug interaction mediated by inhibition of P-glycoprotein
- (2018) Abby C Shumaker et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy
- (2017) Jarrett R. Amsden et al. Expert Opinion on Drug Metabolism & Toxicology
- Risk factors for suboptimal drug concentration of posaconazole oral suspension in patients with hematologic malignancy
- (2017) E.J. Kim et al. JOURNAL DE MYCOLOGIE MEDICALE
- Risk factors for subtherapeutic levels of posaconazole tablet
- (2017) Laura A Tang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
- (2017) Oliver A Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies
- (2017) C. Boglione-Kerrien et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients
- (2017) L. P. Leonart et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- The antifungal pipeline: a reality check
- (2017) John R. Perfect NATURE REVIEWS DRUG DISCOVERY
- Antifungal resistance: current trends and future strategies to combat
- (2017) Nathan Wiederhold Infection and Drug Resistance
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients
- (2016) Kim Vanstraelen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Role of isavuconazole in the treatment of invasive fungal infections
- (2016) Dustin Wilson et al. Therapeutics and Clinical Risk Management
- Visual Hallucinations Associated with High Posaconazole Concentrations in Serum
- (2015) Leighanne O. Parkes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of a High-Fat Meal on the Pharmacokinetics of 300-Milligram Posaconazole in a Solid Oral Tablet Formulation
- (2015) Wendy M. Kersemaekers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Sulfobutylether-β-Cyclodextrin Exposure in a Critically Ill Patient Receiving Intravenous Posaconazole While Undergoing Continuous Venovenous Hemofiltration
- (2015) Amanda A. Morris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes
- (2015) Torsten Dahlén et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2015) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease
- (2015) Kim C. M. van der Elst et al. THERAPEUTIC DRUG MONITORING
- Posaconazole Concentrations in Human Tissues after Allogeneic Stem Cell Transplantation
- (2014) Ola Blennow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects
- (2014) Walter K. Kraft et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects
- (2014) Wendy M. Kersemaekers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis
- (2014) Russell E. Lewis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The role of azoles in the management of azole-resistant aspergillosis: From the bench to the bedside
- (2014) Seyedmojtaba Seyedmousavi et al. DRUG RESISTANCE UPDATES
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-versus-Host Disease
- (2012) J. Tonini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
- (2012) Gopal Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Introduction to Drug Pharmacokinetics in the Critically III Patient
- (2012) Brian S. Smith et al. CHEST
- Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies
- (2012) Mitsutoshi Kurosawa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
- (2012) G. Krishna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- Lack of Evidence for Exposure–Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections
- (2011) O A Cornely et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis
- (2011) Alexander M. Bryant et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Posaconazole Plasma Concentrations in Critically Ill Patients
- (2011) John Ray et al. THERAPEUTIC DRUG MONITORING
- Steady-State Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole in Lung Transplant Recipients
- (2010) J. E. Conte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Serum Concentrations among Cardiothoracic Transplant Recipients: Factors Impacting Trough Levels and Correlation with Clinical Response to Therapy
- (2010) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview
- (2010) Hans-Peter Lipp BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Factors Influencing Pharmacokinetics of Prophylactic Posaconazole in Patients Undergoing Allogeneic Stem Cell Transplantation
- (2009) V. Kohl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
- (2009) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
- (2009) D. Lebeaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis
- (2009) M Reinwald et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment
- (2009) Allen Moton et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
- (2008) G. Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects
- (2008) J. E. Conte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole concentrations in the central nervous system
- (2008) M. J. G. T. Ruping et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2008) Gopal Krishna et al. PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started